Xencor | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
AbbVie USD 5.18B 349M 2025-03
Alnylam Pharmaceuticals USD 1.11B 94.03M 2025-06
Amgen USD 8.03B 782M 2025-06
Arrowhead Research USD 129.79M 55.92M 2025-06
AstraZeneca USD 7.06B 1.83B 2025-06
Biogen USD 2.76B 160.5M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Cytokinetics USD 74.94M 863.28M 2025-06
GlaxoSmithKline GBP 3.6B 865M 2025-06
J&J USD 38.47B 32.35B 2025-03
MacroGenics USD 130.69M 52.15M 2025-06
Merck USD 8.01B 622M 2025-06
Novartis USD 6.66B 410M 2025-06
Pfizer USD 1.64B 208M 2025-06
Regeneron Pharmaceuticals USD 2B 1.09B 2025-06
Roche Holding CHF 6.98B 2.15B 2024-12
Xencor USD 44.44M 4.77M 2025-06


Xencor Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.